Forum Discussion
Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
Hi Wilplaces seems that when you read thereasons for refusing theAustralian pbs listing it comes down to overall cost for number of women to be treated and the time that the drug gives benefit ie 12mths vs 24 months
Those of us who would benefit have been ignored ...we need thses drugs so we can delay chemo
Basically lots more women have hormone positive met breast cancer
We are now being treated unfairly this is a form of. .treatment descrimination based on our sex!
Bright in hope!
Those of us who would benefit have been ignored ...we need thses drugs so we can delay chemo
Basically lots more women have hormone positive met breast cancer
We are now being treated unfairly this is a form of. .treatment descrimination based on our sex!
Bright in hope!